What is the latest cannabis rescheduling update?
The DEA proposed moving cannabis from Schedule I to Schedule III in May 2024, after the Department of Health and Human Services recommended the change. Formal administrative hearings on that proposal opened in January 2025 before DEA Administrative Law Judge John Mulrooney II. No final rule has taken effect, so cannabis remains a Schedule I substance under federal law.
- Stage: proposed rule, not a final rule. The docket stays open while testimony continues.
- Who decides: the administrative law judge issues a recommendation, and the DEA Administrator signs the final order.
- Timing: no date is set. Appeals from either side could add months or years.
- Effect today: Section 280E still applies, banks still treat the industry as high risk, and interstate shipping stays illegal.
How did the rescheduling process get here?
- October 2022: President Biden asked HHS and the Justice Department to review how cannabis is scheduled.
- August 2023: HHS sent the DEA a recommendation to move cannabis to Schedule III.
- May 2024: the DEA published a proposed rule in the Federal Register and opened public comment.
- January 2025: an administrative law judge opened formal hearings on the proposal.
Every step in that chain is administrative. No vote in Congress is required, and no single step completes the change. Only a signed final order from the DEA Administrator moves cannabis to a new schedule.
how would cannabis rescheduling affect prices
What would Schedule III change?
Schedule III holds drugs such as ketamine and codeine-based painkillers. A move to that tier would treat cannabis as a prescription medicine for federal purposes, not as a legal consumer product.
Cannabis Rescheduling vs Legalization: Which Comes First?
- Taxes: Section 280E would no longer block deductions, so licensed operators could write off rent, payroll, and marketing.
- Research: a lower schedule eases registration for studies and for the growers who supply them.
- Banking: no fix on its own. Bank rules track the Controlled Substances Act and related guidance, so relief depends on regulators.
- Patients: a prescription model does not match how state medical programs run today. FDA approval of cannabis flower is not part of the proposal.
What would rescheduling not do?
- It would not end the state-by-state license patchwork.
- It would not allow interstate shipping or imports.
- It would not change age limits, possession rules, or local zoning.
- It would not put cannabis on a pharmacy shelf without FDA action.
Has convenience become the deciding factor in cannabis?
For most shoppers, the choice is not between legal and illegal. It is between the closest option and the one that takes twenty minutes. Rescheduling arguments happen in Washington, but spending moves with drive times, delivery windows, and checkout speed.
cannabis rescheduling impact on laws
Hemp-derived THC moved first
Hemp-derived delta-8 and delta-9 products sit on gas station shelves and in smoke shops, often a short walk from home. They exist because the 2018 Farm Bill drew a line at 0.3 percent delta-9 THC by dry weight, and sellers built a market inside that gap. A Schedule III rule would not touch these products, because they are not scheduled as controlled substances.
Delivery and curbside changed the math
Legal states added delivery, curbside pickup, and drive-thru windows in the years after 2020. A 30-minute round trip to a dispensary competes with a two-minute stop at a corner store, and many customers pick the shorter trip. Shops that borrow retail habits, such as online ordering with a pickup window, keep customers who would otherwise drift to the unlicensed market.
Tax relief could reach the register
If 280E ends, licensed businesses keep more of each dollar. Whether that reaches the price tag depends on competition. In markets with many stores, part of the savings tends to pass to shoppers, and in markets with few licenses it tends to stay with the operator.
What should operators and shoppers watch next?
- The DEA docket. Filings and hearing transcripts post in public before any news coverage.
- The hearing schedule. A judge's recommendation, a comment period, and a final order are three separate events.
- Court appeals. Any final rule is open to challenge, and a stay would pause the change.
- Federal hemp rules. Congress keeps debating the 0.3 percent threshold, which shapes the convenience-store THC market more than rescheduling does.
- State rules. Delivery fees, license caps, and zoning decide convenience long before Washington does.
Frequently asked questions
Is cannabis legal under federal law right now?
No. Cannabis stays on Schedule I until a final rule takes effect. State programs remain legal under state law, and federal agents have not targeted state-licensed businesses in practice.
When will rescheduling take effect?
No date is set. The process runs through hearings, a recommendation, a possible comment period, and a final order. Appeals could stretch that timeline further.
Would Schedule III legalize recreational cannabis?
No. Schedule III drugs are controlled substances that require a prescription. Adult-use sales would stay illegal under federal law and would keep relying on state law.
Does rescheduling change the hemp-derived THC market?
No, not under current scheduling rules. Hemp-derived intoxicating cannabinoids are not scheduled drugs, so DEA scheduling does not cover them. Their future rests on farm bill language and FDA enforcement.
Why does convenience matter more than rescheduling for sales?
Most buyers do not check the Federal Register before a purchase. They pick the fastest option with a price they trust. Convenience decides the sale, and rescheduling decides the margins behind it.